Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Travere Therapeutics, Inc. | 146,919 | reported | 11 May 2022 | tx 92+1,638,036−604,817 |
| BIOCRYST PHARMACEUTICALS INC | 70,159 | reported | 12 Jun 2024 | tx 26+326,686 |
| BIOMARIN PHARMACEUTICAL INC | 59,030 | reported | 02 Jul 2012 | tx 163+1,176,621−880,601 |
| CELL THERAPEUTICS INC | 20,000 | reported | 03 Aug 2004 | tx 6+110,000 |
| PharmaFrontiers Corp. | 0 | reported | 17 Nov 2023 | tx 15+579,241−483,741 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2024 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 6,820 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 49,933 | 0.00 USD | deriv |
| 24 May 2024 | PURCHASE | BIOCRYST PHARMACEUTICALS INC | 2,500 | 6.40 USD | first after silence |
| 17 Nov 2023 | OTHER | PharmaFrontiers Corp. | 483,741 | — | |
| 13 Jun 2023 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 16,745 | 0.00 USD | |
| 13 Jun 2023 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 39,072 | 0.00 USD | deriv |
| 14 Mar 2023 | GRANT_AWARD | PharmaFrontiers Corp. | 20,000 | 0.00 USD | deriv |
| 29 Nov 2022 | PURCHASE | PharmaFrontiers Corp. | 409,836 | 1.22 USD | anomaly |
| 07 Jun 2022 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 12,866 | 0.00 USD | |
| 07 Jun 2022 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 30,022 | 0.00 USD | deriv |
| 31 May 2022 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 569 | 9.31 USD | |
| 11 May 2022 | SALE | Travere Therapeutics, Inc. | 2,575 | 21.92 USD | |
| 28 Feb 2022 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 301 | 16.61 USD | |
| 14 Jan 2022 | GRANT_AWARD | PharmaFrontiers Corp. | 18,500 | 0.00 USD | deriv |
| 09 Dec 2021 | PURCHASE | PharmaFrontiers Corp. | 2,016 | 2.15 USD | first after silenceanomaly |
| 10 Dec 2021 | PURCHASE | PharmaFrontiers Corp. | 7,984 | 2.04 USD | |
| 30 Nov 2021 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 414 | 12.06 USD | |
| 16 Nov 2021 | SALE | Travere Therapeutics, Inc. | 31,800 | 29.39 USD | |
| 05 Nov 2021 | SALE | Travere Therapeutics, Inc. | 10,000 | 26.23 USD | |
| 05 Nov 2021 | EXERCISE | Travere Therapeutics, Inc. | 10,000 | 16.23 USD | |
| 05 Nov 2021 | EXERCISE | Travere Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 01 Nov 2021 | SALE | Travere Therapeutics, Inc. | 5,000 | 29.48 USD | |
| 02 Nov 2021 | SALE | Travere Therapeutics, Inc. | 3,500 | 30.00 USD | |
| 16 Jul 2021 | GIFT | Travere Therapeutics, Inc. | 3,000 | 0.00 USD | |
| 16 Jul 2021 | GIFT | Travere Therapeutics, Inc. | 3,000 | 0.00 USD |
8 purchases reported after at least 12 months of silence — most recent on 24 May 2024.